Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study.

Qiao Y, Fu X, Hussain I, Ge W, Yang W, Jiang R, Dai X, Chen H, Zhao J, Tang M, Mu F, Wang H, Wu Q, Xia X, Zhang Y, Ji S, Xu Y, Cao X, Wang J, Gao L, Wang J, Yao Y, Fang Y.

Open source

DOI: 10.1007/s00262-026-04460-6
Published: 2026-06-23
Container: Cancer Immunol Immunother
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00262-026-04460-6,
  title = {Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study.},
  author = {Qiao Y and  Fu X and  Hussain I and  Ge W and  Yang W and  Jiang R and  Dai X and  Chen H and  Zhao J and  Tang M and  Mu F and  Wang H and  Wu Q and  Xia X and  Zhang Y and  Ji S and  Xu Y and  Cao X and  Wang J and  Gao L and  Wang J and  Yao Y and  Fang Y.},
  year = {2026},
  journal = {Cancer Immunol Immunother},
  doi = {10.1007/s00262-026-04460-6},
  url = {https://doi.org/10.1007/s00262-026-04460-6}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study.
AU  - Qiao Y
AU  -  Fu X
AU  -  Hussain I
AU  -  Ge W
AU  -  Yang W
AU  -  Jiang R
AU  -  Dai X
AU  -  Chen H
AU  -  Zhao J
AU  -  Tang M
AU  -  Mu F
AU  -  Wang H
AU  -  Wu Q
AU  -  Xia X
AU  -  Zhang Y
AU  -  Ji S
AU  -  Xu Y
AU  -  Cao X
AU  -  Wang J
AU  -  Gao L
AU  -  Wang J
AU  -  Yao Y
AU  -  Fang Y.
PY  - 2026
JO  - Cancer Immunol Immunother
DO  - 10.1007/s00262-026-04460-6
UR  - https://doi.org/10.1007/s00262-026-04460-6
ER  -

APA

Y, Q., X, F., I, H., W, G., W, Y., R, J., X, D., H, C., J, Z., M, T., F, M., H, W., Q, W., X, X., Y, Z., S, J., Y, X., X, C., J, W., L, G., J, W., Y, Y., & Y., F. (2026). Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study.. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-026-04460-6

Source records

europe-pmc · retrieved 2026-09-26T15:37:18.124Z
doaj · retrieved 2026-09-26T15:37:18.123Z